These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 3046059

  • 21. Maternal residual beta-cell function and the outcome of diabetic pregnancy.
    Pirttiaho HI, Hartikainen-Sorri AL, Kääpä P, Kaila JM, Puukka R.
    J Perinat Med; 1987; 15(1):83-9. PubMed ID: 3295178
    [Abstract] [Full Text] [Related]

  • 22. Residual insulin secretion is not coupled to a maintained glucagon response to hypoglycaemia in long-term type 1 diabetes.
    Sjöberg S, Ahrén B, Bolinder J.
    J Intern Med; 2002 Oct; 252(4):342-51. PubMed ID: 12366607
    [Abstract] [Full Text] [Related]

  • 23. Residual C-peptide production in type I diabetes mellitus. A comparison of different methods of assessment and influence on glucose control.
    Sjöberg S, Gunnarsson R, Ostman J.
    Acta Med Scand; 1983 Oct; 214(3):231-7. PubMed ID: 6362338
    [Abstract] [Full Text] [Related]

  • 24. Time course of islet cell antibodies and beta-cell function in non-insulin-dependent stage of type I diabetes.
    Kobayashi T, Itoh T, Kosaka K, Sato K, Tsuji K.
    Diabetes; 1987 Apr; 36(4):510-7. PubMed ID: 3545950
    [Abstract] [Full Text] [Related]

  • 25. Clinical application of the 24-H urinary C-peptide excretion rate and its relationship to metabolic control in diabetics.
    Pasquali R, Biso P, Baraldi G, Mattioli L, Capelli M, Pasqui F, Melchionda N.
    Acta Diabetol Lat; 1983 Apr; 20(2):153-61. PubMed ID: 6349203
    [Abstract] [Full Text] [Related]

  • 26. Estimation of B-cell function by the urinary excretion rate of C-peptide in diabetic patients: comparison with C-peptide response to glucagon and to a mixed meal.
    Pasquali R, Buratti P, Biso P, Patrono D, Capelli M, Pasqui F, Melchionda N.
    Diabete Metab; 1987 Feb; 13(1):44-51. PubMed ID: 3552774
    [Abstract] [Full Text] [Related]

  • 27. Partial remission phase and metabolic control in type 1 diabetes mellitus in children and adolescents.
    Böber E, Dündar B, Büyükgebiz A.
    J Pediatr Endocrinol Metab; 2001 Apr; 14(4):435-41. PubMed ID: 11327378
    [Abstract] [Full Text] [Related]

  • 28. Microalbuminuria development in short-term IDDM.
    González-Clemente JM, Esmatjes E, Navarro P, Ercilla G, Casamitjana R, Rios M, Levy I, Gomis R, Vilardell E.
    Diabetes Res Clin Pract; 1994 May; 24(1):15-23. PubMed ID: 7924882
    [Abstract] [Full Text] [Related]

  • 29. Leucine kinetics during a brief fast in diabetes in pregnancy.
    Kalhan SC, Denne SC, Patel DM, Nuamah IF, Savin SM.
    Metabolism; 1994 Mar; 43(3):378-84. PubMed ID: 8139488
    [Abstract] [Full Text] [Related]

  • 30. Food constituents as a cause of variation of C-peptide excretion in the urine.
    Takai K, Nonaka K, Ichihara K, Tarui S.
    Endocrinol Jpn; 1984 Jun; 31(3):291-9. PubMed ID: 6389101
    [Abstract] [Full Text] [Related]

  • 31. Renal metabolism of C-peptide in patients with early insulin-dependent diabetes mellitus.
    Robaudo C, Zavaroni I, Garibotto G, Deferrari G.
    Nephron; 1996 Jun; 72(3):395-401. PubMed ID: 8852486
    [Abstract] [Full Text] [Related]

  • 32. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S, Torlone E, Ialli C, Del Sindaco P, Ciofetta M, Lepore M, Bartocci L, Brunetti P, Bolli GB.
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [Abstract] [Full Text] [Related]

  • 33. Hyperglycemia facilitates urinary excretion of C-peptide by increasing glomerular filtration rate in non-insulin-dependent diabetes mellitus.
    Wasada T, Kuroki H, Arii H, Maruyama A, Katsumori K, Aoki K, Saito S, Omori Y.
    Metabolism; 1995 Sep; 44(9):1194-8. PubMed ID: 7666795
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Correlation between minimal secretory capacity of pancreatic beta-cells and stability of diabetic control.
    Fukuda M, Tanaka A, Tahara Y, Ikegami H, Yamamoto Y, Kumahara Y, Shima K.
    Diabetes; 1988 Jan; 37(1):81-8. PubMed ID: 3275557
    [Abstract] [Full Text] [Related]

  • 36. Diurnal profiles of intermediary metabolites in insulin-dependent diabetes and their relationship to different degrees of residual B-cell function.
    Madsbad S, Faber OK, Binder C, Alberti KG, Lloyd B.
    Acta Diabetol Lat; 1981 Jan; 18(2):115-21. PubMed ID: 7018146
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Urine C-peptide after recovery from diabetic ketoacidosis: an index of insulin dependency.
    Matsuda A, Kuzuya T.
    Diabetes Care; 1982 Jan; 5(6):581-4. PubMed ID: 6821491
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.